Cargando…
The race for antimicrobials in the multidrug resistance era
The appearance of multidrug‐resistant pathogens is a major threat to human health with the reemergence of fatal and untreatable diseases. In addition to a rational use of the well‐known and available antibiotics, two complementary ways to overcome this public health issue are (i) the discovery of ne...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196379/ https://www.ncbi.nlm.nih.gov/pubmed/29205906 http://dx.doi.org/10.1111/1751-7915.12884 |
_version_ | 1783364544403341312 |
---|---|
author | Molina‐Santiago, Carlos de Vicente, Antonio Romero, Diego |
author_facet | Molina‐Santiago, Carlos de Vicente, Antonio Romero, Diego |
author_sort | Molina‐Santiago, Carlos |
collection | PubMed |
description | The appearance of multidrug‐resistant pathogens is a major threat to human health with the reemergence of fatal and untreatable diseases. In addition to a rational use of the well‐known and available antibiotics, two complementary ways to overcome this public health issue are (i) the discovery of new antimicrobials and (ii) the chemical modification of pre‐existing potent antibiotics. In this article, we highlight some of the strategies to generate new and promising antimicrobials for use in the management of these so‐called ‘superbugs’. |
format | Online Article Text |
id | pubmed-6196379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61963792018-10-30 The race for antimicrobials in the multidrug resistance era Molina‐Santiago, Carlos de Vicente, Antonio Romero, Diego Microb Biotechnol Opinion The appearance of multidrug‐resistant pathogens is a major threat to human health with the reemergence of fatal and untreatable diseases. In addition to a rational use of the well‐known and available antibiotics, two complementary ways to overcome this public health issue are (i) the discovery of new antimicrobials and (ii) the chemical modification of pre‐existing potent antibiotics. In this article, we highlight some of the strategies to generate new and promising antimicrobials for use in the management of these so‐called ‘superbugs’. John Wiley and Sons Inc. 2017-12-04 /pmc/articles/PMC6196379/ /pubmed/29205906 http://dx.doi.org/10.1111/1751-7915.12884 Text en © 2017 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Opinion Molina‐Santiago, Carlos de Vicente, Antonio Romero, Diego The race for antimicrobials in the multidrug resistance era |
title | The race for antimicrobials in the multidrug resistance era |
title_full | The race for antimicrobials in the multidrug resistance era |
title_fullStr | The race for antimicrobials in the multidrug resistance era |
title_full_unstemmed | The race for antimicrobials in the multidrug resistance era |
title_short | The race for antimicrobials in the multidrug resistance era |
title_sort | race for antimicrobials in the multidrug resistance era |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196379/ https://www.ncbi.nlm.nih.gov/pubmed/29205906 http://dx.doi.org/10.1111/1751-7915.12884 |
work_keys_str_mv | AT molinasantiagocarlos theraceforantimicrobialsinthemultidrugresistanceera AT devicenteantonio theraceforantimicrobialsinthemultidrugresistanceera AT romerodiego theraceforantimicrobialsinthemultidrugresistanceera AT molinasantiagocarlos raceforantimicrobialsinthemultidrugresistanceera AT devicenteantonio raceforantimicrobialsinthemultidrugresistanceera AT romerodiego raceforantimicrobialsinthemultidrugresistanceera |